Optex Systems (OPXS) director and 10% owner logs Rule 10b5-1 stock sales

Rhea-AI Filing Summary

Optex Systems Holdings Inc. director and 10% owner Danny Robert Schoening reported automatic sales of common stock under a pre-arranged Rule 10b5-1 trading plan. On January 7, 2026, he sold 27,946 shares at a weighted average price of $13.44 per share. On January 8, 2026, he sold 2,815 shares at a weighted average price of $13.55 and 26,109 shares at a weighted average price of $14.11, all in multiple trades within the stated price ranges. Following these transactions, Schoening directly beneficially owned 796,730 shares of Optex common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHOENING DANNY ROBERT

(Last) (First) (Middle)

1420 PRESIDENTIAL DRIVE

(Street)

RICHARDSON TX 75081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Optex Systems Holdings Inc [ OPXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	01/07/2026		S		27,946(1)	D	$13.44(2)	825,654	D
COMMON STOCK	01/08/2026		S		2,815(1)	D	$13.55(3)	822,839	D
COMMON STOCK	01/08/2026		S		26,109(1)	D	$14.11(4)	796,730	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.1850 to $13.7500 per share, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.0600 to $13.7500 per share, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.7600 to $14.3000 per share, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Roland S. Chase as attorney in fact for Danny Robert Schoening	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who reported insider transactions in Optex Systems (OPXS)?

The reporting person is Danny Robert Schoening, who is listed as both a director and a 10% owner of Optex Systems Holdings Inc.

What type of Optex Systems (OPXS) securities were involved in the Form 4?

The transactions involved common stock of Optex Systems Holdings Inc., reported as non-derivative securities.

When did the Optex Systems (OPXS) insider sales take place?

The reported sales took place on January 7, 2026 and January 8, 2026, according to the Form 4.

How many Optex Systems (OPXS) shares did the insider sell and at what prices?

The insider sold 27,946 shares at a weighted average price of $13.44 on January 7, 2026, and on January 8, 2026 sold 2,815 shares at a weighted average price of $13.55 and 26,109 shares at a weighted average price of $14.11. Each price represents a weighted average over multiple trades within the stated ranges.

How many Optex Systems (OPXS) shares does the insider hold after these transactions?

After the reported sales, Danny Robert Schoening directly beneficially owned 796,730 shares of Optex Systems common stock.

Were the Optex Systems (OPXS) insider sales under a Rule 10b5-1 trading plan?

Yes. A footnote states that the reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

What do the weighted average prices mean in the Optex Systems (OPXS) Form 4?

The filing explains that each reported price is a weighted average price for multiple trades executed within specified price ranges, and that detailed trade information is available upon written request.